Dual Peptide-Modified Nanoparticles Improve Combination Chemotherapy of Etoposide and siPIK3CA Against Drug-Resistant Small Cell Lung Carcinoma

Small cell lung carcinoma (SCLC) is a highly aggressive form of malignancy with rapid recurrence and poor prognosis. The dual peptide-modified nanoparticles (NPs) for improving chemotherapy against drug-resistant small cell lung carcinoma cells has been developed. In this study, the SCLC targeting l...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Hsin-Lin, Lin, Wen Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150975/
https://www.ncbi.nlm.nih.gov/pubmed/32178266
http://dx.doi.org/10.3390/pharmaceutics12030254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150975/
https://www.ncbi.nlm.nih.gov/pubmed/32178266
http://dx.doi.org/10.3390/pharmaceutics12030254

Ejemplares similares